686 related articles for article (PubMed ID: 34627838)
1. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
Englund DA; Zhang X; Aversa Z; LeBrasseur NK
Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases.
Lee HJ; Yoon YS; Lee SJ
J Mol Biol; 2023 Jun; 435(12):168114. PubMed ID: 37085010
[TBL] [Abstract][Full Text] [Related]
4. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome.
Tanaka T; Urata Y; Harada M; Kunitomi C; Kusamoto A; Koike H; Xu Z; Sakaguchi N; Tsuchida C; Komura A; Teshima A; Takahashi N; Wada-Hiraike O; Hirota Y; Osuga Y
Mol Hum Reprod; 2024 Apr; 30(5):. PubMed ID: 38603629
[TBL] [Abstract][Full Text] [Related]
6. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Senolytics in Cardiovascular Disease.
Dookun E; Passos JF; Arthur HM; Richardson GD
Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
[TBL] [Abstract][Full Text] [Related]
8.
Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
10. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
11. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
12. The Cancer SENESCopedia: A delineation of cancer cell senescence.
Jochems F; Thijssen B; De Conti G; Jansen R; Pogacar Z; Groot K; Wang L; Schepers A; Wang C; Jin H; Beijersbergen RL; Leite de Oliveira R; Wessels LFA; Bernards R
Cell Rep; 2021 Jul; 36(4):109441. PubMed ID: 34320349
[TBL] [Abstract][Full Text] [Related]
13. Emerging senolytic agents derived from natural products.
Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
[TBL] [Abstract][Full Text] [Related]
14. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
Kang C
Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837
[TBL] [Abstract][Full Text] [Related]
15. Cellular senescence in brain aging and neurodegeneration.
Melo Dos Santos LS; Trombetta-Lima M; Eggen B; Demaria M
Ageing Res Rev; 2024 Jan; 93():102141. PubMed ID: 38030088
[TBL] [Abstract][Full Text] [Related]
16. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration.
Richardson M; Richardson DR
Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616
[TBL] [Abstract][Full Text] [Related]
18. A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials.
Gonzales MM; Krishnamurthy S; Garbarino V; Daeihagh AS; Gillispie GJ; Deep G; Craft S; Orr ME
Mech Ageing Dev; 2021 Dec; 200():111589. PubMed ID: 34687726
[TBL] [Abstract][Full Text] [Related]
19. Cellular senescence and the aging brain.
Chinta SJ; Woods G; Rane A; Demaria M; Campisi J; Andersen JK
Exp Gerontol; 2015 Aug; 68():3-7. PubMed ID: 25281806
[TBL] [Abstract][Full Text] [Related]
20. Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases.
Wissler Gerdes EO; Zhu Y; Weigand BM; Tripathi U; Burns TC; Tchkonia T; Kirkland JL
Int Rev Neurobiol; 2020; 155():203-234. PubMed ID: 32854855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
